Familial segregation of hemangiomas and vascular malformations as an autosomal dominant trait

Archives of Dermatology

Volumn 134, Issue 6, 1998, Pages 718-722

  Blei, Francine ^a,c   Walter, Jeffrey ^b   Orlow, Seth J ^a   Marchuk, Douglas A ^b  

^a NEW YORK UNIVERSITY   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH FACTOR;

ADULT; ANGIOGENESIS; ARTICLE; AUTOSOMAL DOMINANT DISORDER; CLINICAL ARTICLE; CLINICAL FEATURE; CONGENITAL BLOOD VESSEL MALFORMATION; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; FAMILIAL DISEASE; FEMALE; HISTORY OF MEDICINE; HUMAN; HUMAN TISSUE; MALE; PATHOGENESIS; PRIORITY JOURNAL; SKIN HEMANGIOMA;

ARTERIOVENOUS MALFORMATIONS; CHROMOSOME ABERRATIONS; CHROMOSOME DISORDERS; FEMALE; GENES, DOMINANT; HEMANGIOMA; HUMANS; MALE; PEDIGREE; SKIN NEOPLASMS;

EID: 0031800996     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archderm.134.6.718     Document Type: Article

References (15)

1. Mulliken JB, Young AE, eds. Vascular Birthmarks: Hemangiomas and Vascular Malformations. Philadelphia, Pa: WB Saunders Co; 1988.
2. Takahashi K, Mulliken J, Kozakewich H, Rogers R, Folkman J, Ezekowitz RAB. Cellular markers that distinguish the phases of hemangiomas during infancy and childhood. J Clin Invest. 1994:93:2357-2364.
3. Kraling B, Razon MJ, Boon LM, et al. E-selectin is present in proliferating endothelial cells in human hemangiomas. Am J Pathol. 1996;148:1181-1191.
4. Martin-Padura I, DeCastellarnau C, Uccini S, et al. Expression of VE (vascular endothelial)-cadherin and other endothelial-specific markers in hemangiomas. J Pathol. 1995;175:51-57.
5. Berard M, Sordello S, Ortega N, et al. Vascular endothelial growth factor confers a growth advantage in vitro and in vivo to stromal cells cultured from neonatal hemangiomas. Am J Pathol. 1997;150:1315-1326.
6. Burns AJ, Kaplan LC, Mulliken JB. Is there an association between hemangiomas and syndromes with dysmorphic features? Pediatrics. 1991;88:1257-1267.
7. Reese V, Frieden I, Paller AS, et al. Association of facial hemangiomas with Dandy-Walker and other posterior fossa malformations. J Pediatr. 1993;122:379-384.
8. Goh WHS, Lo R. A new 3C syndrome: cerebellar hypoplasia, cavernous hemangioma and coarctation of the aorta. Dev Med Child Neurol. 1993;35:631-641.
9. Frieden IJ, Reese V, Cohen D. PHACE syndrome: the association of posterior fossa brain malformations, hemangiomas, arterial anomalies, coarctation of the aorta and cardiac defects, and eye abnormalities. Arch Dermatol. 1996:132:307-311.
10. Pascual-Castroviejo I, Viano J, Palencia R, et al. Hemangiomas of the head, neck, and chest with associated vascular and brain abnormalities: a complex neurocutaneous syndrome. AJNR Am J Neuroradiol. 1996;17:461-471.
11. Schieken LS, Brenner JI, Baker KR, Ringel RE, Pacifico A. Aneurysm of the ascending aorta associated with sternal cleft, cutaneous hemangioma, arid occlusion of the right innominate artery in a neonate. Am Heart J. 1987;113:202-204.
12. Gorlin RJ, Kantaputra P, Aughton FJ, Mulliken JB. Marked female predilection in some syndromes associated with facial hemangiomas. Am J Med Genet. 1994: 52:130-135.
13. Mulliken JB, Glowacki J. Hemangiomas and vascular malformations in infants and children: a classification based on endothelial characteristics. Plast Reconstr Surg. 1982;69:412-420.
14. Cheung DS, Warman ML, Mulliken JB. Hemangioma in twins. Ann Plast Surg. 1997:38:269-274.
15. Vikkula M, Boon LM, Carraway KL, et al. Vascular dysmorphogenesis caused by an activating mutation in the receptor tyrosine kinase tie-2. Cell. 1996:87:1181-1190.